JPH11222440A5 - - Google Patents

Info

Publication number
JPH11222440A5
JPH11222440A5 JP1998021809A JP2180998A JPH11222440A5 JP H11222440 A5 JPH11222440 A5 JP H11222440A5 JP 1998021809 A JP1998021809 A JP 1998021809A JP 2180998 A JP2180998 A JP 2180998A JP H11222440 A5 JPH11222440 A5 JP H11222440A5
Authority
JP
Japan
Prior art keywords
pth
leukopenia
cells
administration
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998021809A
Other languages
English (en)
Japanese (ja)
Other versions
JP4414494B2 (ja
JPH11222440A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP02180998A priority Critical patent/JP4414494B2/ja
Priority claimed from JP02180998A external-priority patent/JP4414494B2/ja
Publication of JPH11222440A publication Critical patent/JPH11222440A/ja
Publication of JPH11222440A5 publication Critical patent/JPH11222440A5/ja
Application granted granted Critical
Publication of JP4414494B2 publication Critical patent/JP4414494B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP02180998A 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤 Expired - Fee Related JP4414494B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP02180998A JP4414494B2 (ja) 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02180998A JP4414494B2 (ja) 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤

Publications (3)

Publication Number Publication Date
JPH11222440A JPH11222440A (ja) 1999-08-17
JPH11222440A5 true JPH11222440A5 (enrdf_load_stackoverflow) 2005-07-07
JP4414494B2 JP4414494B2 (ja) 2010-02-10

Family

ID=12065393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP02180998A Expired - Fee Related JP4414494B2 (ja) 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤

Country Status (1)

Country Link
JP (1) JP4414494B2 (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335501C (zh) 1996-09-26 2007-09-05 中外制药株式会社 抗人副甲状腺激素相关蛋白的抗体
CA2289910A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for cachexia
EP1197225A4 (en) * 1999-07-02 2006-02-22 Chugai Pharmaceutical Co Ltd AGENTS FOR DISEASES CAUSED BY PTH OR PTHrH
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
EP1283057B2 (en) 2000-04-28 2012-05-30 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitors

Similar Documents

Publication Publication Date Title
RU2128056C1 (ru) Способы и препараты для лечения заболеваний интерфероном, характеризующиеся сниженными побочными эффектами
JP2914393B2 (ja) ヒトサイトカイン、インターロイキン―９
ES2380009T3 (es) Métodos para movilizar las células madre/progenitoras
JP4416839B2 (ja) 二次性免疫不全症の治療法
US6719969B1 (en) Treatment of liver disease and injury with CXC chemokines
JPH10510147A (ja) 二次性免疫不全症の治療用薬剤の製造方法
JP2846629B2 (ja) 組換えコロニー刺激因子−１を含んで成る医薬組成物
MXPA06000017A (es) Combinacion farmaceutica de factor estimulador de colonias de granulocitos y factor de crecimiento placentario util para hemocitoblastos.
US5104653A (en) Use of human interferon-beta for stimulation of erythropoiesis
JP3496937B2 (ja) コンセンサスヒトインターフェロンを含有する細胞増殖障害治療用の医用組成物
AU664210B2 (en) Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
JPH11222440A5 (enrdf_load_stackoverflow)
JP4414494B2 (ja) 白血球減少症の予防剤および治療剤
Gabrilove et al. Granulocyte colony-stimulating factor: preclinical and clinical studies
JPH04506818A (ja) 造血細胞の成熟
Parker et al. Inhibitors of haemopoiesis and their potential clinical relevance
JP2597953B2 (ja) 制癌剤
US20030099637A1 (en) Remedies for interstitial pneumonia , method of constructing animal model of this disease, and screening method with the use of the same
WO2004016258A1 (en) Therapeutical use of guanylhydrazones for treating diseases associated with dendritic cell maturation
CA2106821A1 (en) Glycosylated cytokines
JPH04218365A (ja) 動物細胞増殖促進剤及び無血清培地
JP2002510641A (ja) 神経退化疾患治療用短ペプチド
WO2001010899A2 (en) Treatment of liver disease and injury with cxc chemokines
Hoyos-Bachiloglu et al. Precision medicine as treatment for primary immunodeficiency and immune dysregulation
JP2007505128A (ja) 造血を高める方法